• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL (BD WEST) MEDICAL SURGICAL BD POSIFLUSH¿ 4% SODIUM CITRATE FILL; FLUSH SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL (BD WEST) MEDICAL SURGICAL BD POSIFLUSH¿ 4% SODIUM CITRATE FILL; FLUSH SYRINGE Back to Search Results
Catalog Number 303270
Device Problems Volume Accuracy Problem (1675); Free or Unrestricted Flow (2945); Illegible Information (4050)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/10/2019
Event Type  malfunction  
Manufacturer Narrative
Device evaluated by mfr: a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation and/or device history review, a supplemental report will be filed.
 
Event Description
Material no.303270, batch no.8204589.It was reported that during use of the bd posiflush¿ 4% sodium citrate fill "air entered the syringe again just prior to instilling this to the cvc lumen." in speaking with nurses, other concerns have to do with the label on the syringe.The label is not completely transparent and on most syringes, the label is irregularly bubbled in its application on the syringe and if the bubbling of the label occurs where the graduations are, it is more challenging to ensure correct volume of administration.The following information was provided by the initial reporter: we have implemented the use of the bd sodium citrate syringes in our hemodialysis program.I recently had the opportunity to use the posiflush citrate syringe and i found that after expelling the air and excess na citrate from the syringe (we instill 2.5ml to each lumen), i noticed that air entered the syringe again just prior to instilling this to the cvc lumen.I discussed with our epl, and a few other nurses have raised this concern.Vac, and i met yesterday to review our use of the posiflush syringe and to try and recreate this in simulation, and there may have been a negligible amount of air enter the tip, but not what i had experienced with first use.
 
Manufacturer Narrative
H.6.Investigation: five representative samples were received.The packaging flow wrap was removed from each sample.Visual inspection was performed finding the barrel label in its correct position.The barrel label application is also correct.Nothing wrong was observed on the barrel label with regards to transparency.A device history record review was completed with zero defects found.No quality notifications were written for this batch, nor for the associated assembly batches.
 
Event Description
Material no.303270, batch no.8204589.It was reported that during use of the bd posiflush¿ 4% sodium citrate fill "air entered the syringe again just prior to instilling this to the cvc lumen." in speaking with nurses, other concerns have to do with the label on the syringe.The label is not completely transparent and on most syringes, the label is irregularly bubbled in its application on the syringe and if the bubbling of the label occurs where the graduations are, it is more challenging to ensure correct volume of administration.The following information was provided by the initial reporter: we have implemented the use of the bd sodium citrate syringes in our hemodialysis program.I recently had the opportunity to use the posiflush citrate syringe and i found that after expelling the air and excess na citrate from the syringe (we instill 2.5ml to each lumen), i noticed that air entered the syringe again just prior to instilling this to the cvc lumen.I discussed with our epl, and a few other nurses have raised this concern.Vac, and i met yesterday to review our use of the posiflush syringe and to try and recreate this in simulation, and there may have been a negligible amount of air enter the tip, but not what i had experienced with first use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH¿ 4% SODIUM CITRATE FILL
Type of Device
FLUSH SYRINGE
Manufacturer (Section D)
BD MEDICAL (BD WEST) MEDICAL SURGICAL
1852 10th avenue
columbus NE 68601
MDR Report Key8656055
MDR Text Key147514313
Report Number1911916-2019-00544
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 06/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Catalogue Number303270
Device Lot Number8204589
Initial Date Manufacturer Received 05/10/2019
Initial Date FDA Received05/30/2019
Supplement Dates Manufacturer Received05/10/2019
Supplement Dates FDA Received06/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-